Clinical Trial

Cryotherapy for Reducing Fistula Puncture Pain in Hemodialysis Patients

Study acronym: CRYO-AVF
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
People on hemodialysis need their arteriovenous fistula (a blood vessel access point) punctured with a needle three times a week, which can cause pain and worry. This study compares three ways of managing that pain: (1) usual care, (2) applying an ice pack to a specific point on the hand before the needle is inserted (cryotherapy), and (3) applying a numbing gel (lidocaine/prilocaine) to the skin before the needle is inserted. Adult hemodialysis patients with a working fistula were randomly assigned to one of these three groups. Over three dialysis sessions, researchers measured each patient's pain, anxiety, and other symptoms right before, right after, during, and after dialysis, as well as their quality of life and a physical stress marker (heart rate variability). The goal is to find out whether the ice pack method works as well as or better than usual care and the numbing gel at reducing pain and anxiety, so that a simple, low-cost, non-drug option could be offered to more patients in the future.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-02.
Trial Details
NCT Number NCT07694271
Lead Sponsor Taipei Medical University
Conditions Pain, Procedural (During Sternum Dressing on Infants), Arteriovenous Fistula, Kidney Failure, Chronic
Enrollment 150 participants
Start Date 2025-02-25
Primary Completion 2026-07-24 (estimated)
Study Completion 2026-07-24 (estimated)
Updated on ClinicalTrials.gov 2026-07-27